Medical Promotion of Cholesterol-lowering Drugs Biased

Medical Promotion of Cholesterol-lowering Drugs Biased – Not Based on Scientific Evidence

A group of independent medical academics challenged a recently published BMJ (British Medical Journal) 20 year follow-up study that claimed favorable results among those using statins as a preventative measure. It was known as the West of Scotland Coronary Prevention Study (WOSCOPS), the first trial attempting to demonstrate a significant reduction in cardiovascular events with statin therapy for primary prevention.

The critical report challenging the BMJ’s statin-promotion based on the WOSCOPS study was published recently, October of 2017. The challenging trio of medical scientists, led by independent researcher Uffe Ravnskov MD, PhD, author of The Cholesterol Myth and [You must be registered and logged in to see this link.], parsed and picked at the study to show it is flawed.




This information is just a short part of what can be found here >>>

[You must be registered and logged in to see this link.]

Cholesterol Lowering Drug Scandal: CoQ10 Essential to Senior Health but Depleted by Statins

What would motivate a retired married couple to attempt a petition demanding a policy of advising CoQ10 when doctors prescribe cholesterol-lowering statin drugs?

In Japan it is required to prescribe CoQ10 with statin drugs, but not in the U.S.

The least publicized actual side effect of cholesterol-lowering statin drugs that complements the dangerous intended effect of reducing cholesterol is they also block CoQ10 production, which is already waning among those aged 40 and older.




To read more >>>

[You must be registered and logged in to see this link.]